[Human papillomavirus and cervical neoplasia]. (Q43986168)

28 November 2017

1 reference

title

[Human papillomavirus and cervical neoplasia]. (English)

1 reference

28 November 2017

Maria Inês da Rosa

1

1 reference

28 November 2017

Lídia Rosi Medeiros

2

1 reference

28 November 2017

Daniela Dornelles Rosa

3

1 reference

28 November 2017

Mary Clarisse Bozzeti

4

1 reference

28 November 2017

Fábio Rosa Silva

5

1 reference

28 November 2017

Bruno Rosa Silva

6

1 reference

28 November 2017

language of work or name

non-English

0 references

publication date

1 May 2009

1 reference

Cadernos de saúde pública

28 November 2017

published in

1 reference

28 November 2017

volume

25

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

953-964

1 reference

Global cancer statistics in the year 2000.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

21 January 2018

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Cancer of the Uterine Cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Persistent human papillomavirus infection and cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Arrangement of L2 within the papillomavirus capsid

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Molecular events in uterine cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Interactions between papillomavirus L1 and L2 capsid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Assembly and translocation of papillomavirus capsid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Human papillomavirus molecular biology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Human papillomavirus infection and cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Induction and bypass of p53 during productive infection by polyomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Cell-cycle checkpoints and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Telomerase activation by the E6 gene product of human papillomavirus type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Accuracy of telomerase in cervical lesions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Natural history of cervicovaginal papillomavirus infection in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Human papillomavirus prevalence at the USA-Mexico border among women 40 years of age and older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

The Bali STD/AIDS study: human papillomavirus infection among female sex workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Host and viral genetics and risk of cervical cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

The epidemiology of human papillomavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Cervical cancer and use of hormonal contraceptives: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Monthly combined injectable contraceptives and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Tobacco use and cancer causation: association by tumour type

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Cigarette smoking and cervical cancer: Part I: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Active and passive cigarette smoking and the risk of cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

The Pierre Denoix Memorial Lecture: nature and nurture in the control of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Carotenoids as antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

A case-control study of nutrient status and invasive cervical cancer. II. Serologic indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Content of alpha-tocopherol in blood serum of human Papillomavirus-infected women with cervical dysplasias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Oxidant stress and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Prophylactic human papillomavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

Invasive cervical cancer as an AIDS-defining illness in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-311X2009000500002

10.1590/S0102-311X2009000500002

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference